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ABSTRACT:  
Background: We have evaluated the rationale of existing grading and staging schemes of 
oral submucous fibrosis (OSMF) based on how they are categorized. A novel classification 
and staging scheme is proposed. 
Methods: 300 OSMF patients were evaluated for agreement between functional, clinical and 
histopathological staging. Bilateral biopsies were assessed in 25 patients to evaluate for any 
differences in histopathological staging of OSMF in the same mouth. Extent of clinician 
agreement for categorized staging data was evaluated using Cohen’s weighted Kappa 
analysis. Cross-tabulation was performed on categorical grading data to understand the 
intercorrelation and the unweighted kappa analysis was used to assess the bilateral grades 
agreement. Probabilities of less than 0.05 were considered significant. Data were analyzed 
using SPSS Statistics (version 25.0, IBM, USA). 
Results: A low agreement was found between all the stages depicting the independent nature 
of trismus, clinical features and histopathological components (K= 0.312, 0.167, 0.152) in 
OSMF. Following analysis, a three component classification schemes (TFM classification) 
was developed that describes the severity of each independently, grouping them using a novel 
three tier staging scheme as a guide to the treatment plan.  
Conclusion: The proposed classification and staging could be useful for effective 
communication, categorization and, recording data and prognosis, and for guiding treatment 
plans. Furthermore the classification considers OSMF malignant transformation in detail. 
Key words: Oral Submucous fibrosis; Potentially malignant disorder; TFM Classification; 
TFM Staging; Malignant transformation 
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INTRODUCTION:  
Oral submucous fibrosis (OSMF) is a chronic, debilitating condition of the oral cavity 
causing progressive scarring of the oral mucosa.1 There has been recent discussion regarding 
the classification and staging of OSMF.2,3 Though no individual clinical variants of OSMF 
exist, several classification schemes have been described in the literature.2-18 In reality, 
existing classification schemes are essentially staging and grading systems of OSMF rather 
than being true classifications. The current schemes of OSMF stage and grade are based 
solely on a diagnosis of the predominant lesions instead of potential changes in the entire oral 
cavity. The simple subdivision of the severity of OSMF into different stages should perhaps 
not form the principal basis for classification. 
The most important factors in managing OSMF are the functional and clinical staging of the 
disease with information on any malignant transformation.19 Once the degree of severity of 
OSMF is established, histology guides appropriate patient management.2  However, despite 
years of research, there is still no staging or grading scheme universally accepted and 
employed by clinicians, pathologists and surgeons.2 Since the original proposal of the 
histological grading and clinical staging system by Pindborg et al.8, 9 there has been a wealth 
of information published on both clinical and histopathological features of OSMF. Surely it is 
now time to rethink the way in which the OSMF patients are evaluated and classified. 
The purpose of this paper is to evaluate the rationale of existing grading and staging schemes 
of oral submucous fibrosis (OSMF) based on which they are categorized. A novel 
classification, staging and grading scheme is proposed which takes into consideration 
independent functional and clinical findings, together with information on any malignant 
transformation of OSMF.  
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MATERIALS ANS METHODS  
Following Ethical Committee Approval from the institutional review board, the study was 
conducted in Shahapur of the Yadgir district, Hyderabad-Karnataka region, India. Written 
consent was obtained from all patients. 
300 patients with clinically diagnosed OSMF were randomly recruited for the study. All 
those selected had a ‘WHO performance status and comorbidity score’ 20, 21 of either 0 or 1. 
All OSMF patients recruited chewed gutkha (crushed areca nut, tobacco, catechu, paraffin 
wax, slaked lime and sweet or savoury fillings) or areca nut. 
The study was conducted in three stages.  
Stage 1: The clinicopathological classification system currently the most widely accepted by 
Khanna and Andrade19 was analysed to evaluate concordance between function and clinical 
presentation. Functional, clinical and histopathological features were analysed separately for 
convenience and recorded as shown in Tables 1 and 2. To ease the comparison, the subset 
features of stage 4a and 4b are considered together as a single group.    
All patients were examined to record functional and clinical stage of OSMF and the results 
documented by one of the authors (GA). To assess the correlation between the staging and 
number of affected surfaces, we divided the oral mucosal surfaces into 6 sites: right and left 
buccal mucosa, tongue, lip, floor of mouth, and oropharynx. The affected surfaces were 
documented in each patient and tabulated. 
Stage 2:  From the 300 patients recruited to this study, those with bilateral buccal OSMF 
were listed separately and 50 patients were randomly selected. 3/50 patients could not be 
categorized on grading scores due to severe trismus, and therefore were not included, so a 
total of 47 patients were included in the analysis.  All 47 patients underwent incisional biopsy 
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of the most prominent buccal lesion and the disease was histologically graded by one of the 
authors (SH) using histopathological features proposed by Khanna and Andrade 19 (Table 2). 
The grades were documented and tabulated to discern a correlation between staging and 
histological grading.  
Stage 3:  25 patients were randomly selected from the 47 patients with bilateral buccal 
OSMF included as above. All 25 patients underwent a further biopsy of the contra lateral 
OSMF buccal mucosa and were histologically graded by the same pathologist. All grades 
were tabulated to evaluate any differences with bilateral grading.  
Statistical analysis 
Nominal (categorical) data was analysed and assessed for agreement and correlation. The 
extent of agreement between categorized staging data was done using Cohens weighted 
Kappa analysis. McHugh’s guidelines22 were used to interpret kappa in the study. The 
correlation between staging (clinical and functional) and the number of affected surfaces was 
performed using Spearman's rank correlation coefficient.  Cross tabulation was done on 
categorical grading data to understand inter-correlation and unweighted kappa analysis was 
used to assess bilateral grades agreement. Probabilities of less than 0.05 were considered 
significant. SPSS Statistics for Windows (version 25.0, IBM Corp, Armonk, USA) was used 
for data analysis. 
RESULTS 
The mean age of the 300 patients recruited to this study was 22.0 years (SD +/-8 years).   
Stage 1:  All 300 patients recruited were assessed for the extent of OSMF. Agreement 
between functional and clinical staging was assessed using Cohens weighted Kappa. The 
correlation between staging (clinical and functional) and number of affected surfaces was 
assessed using Spearman's rank correlation coefficient.  
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The agreement between functional and clinical staging was relatively low (k = 0.312). The 
correlations between the clinical staging and number of affected surfaces (Spearman’s rho = 
0.152) and functional staging and number of affected surfaces (Spearman’s rho = -0.135) had 
no statistical or clinically significant relationship (effect size = 0.144). 
Stage 2: From the population sample of 300, a random sample of 47 patients who had 
mucosal biopsies was analyzed for agreement between staging (clinical and functional) and 
histopathological grading.  
Cohen’s weighted kappa (k =0.167) quantified the extent of complete or near agreement 
between clinical staging and grading data, with a weighted agreement of 17%, indicating a 
poor agreement between clinical staging and histopathological grading.  
Cohen’s weighted kappa (k = 0.152) also demonstrated a similar level of weighted agreement 
between functional staging and histological grading depicting a low agreement between these 
two categories.   
Stage 3: Kappa analysis was used to assess potential agreement between bilateral 
histopathology grading of OSMF, in the 25 patients who had bilateral buccal mucosa 
biopsies. The unweighted kappa value of -0.478 (p<.001) indicated that there was very little 
chance of agreement between the two grading categories. To further understand the 
correlation between the bilateral grading, cross-tabulation was performed on categorical data 
(Table 3). The tabulation showed no complete agreement between the bilateral 
histopathological grades in any of the 25 patients who had bilateral buccal mucosal biopsies 
(the highlighted diagonal shows zero throughout table 2).   
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DISCUSSION  
Several staging systems based on different aspects of OSMF have been suggested to aid 
classification.2-19 Existing staging systems can be broadly categorized into clinical staging, 
histological staging, and clinicopathological Staging. The earliest staging by Pindborg and 
Sirsat9 in 1966 was based on histopathological features and was updated in 2005 by 
Utsunomiya et al.10  Wahi et al.11 presented the first clinical staging (of 3 groups) based on 
symptoms, and subsequently several others have been proposed.2-18 Khanna and Andrade 
combined both histopathological and clinical features of the disease, and developed a staging 
in the form of groups to aid surgical management.19  Another has proposed a grading system 
which incorporates any incidence of other potentially malignant disorders (including 
dysplasia) with traditional clinical findings. Others have categorized OSMF into two staging 
systems; clinical and functional. 2 Clinical includes OSMF symptoms and any associated 
premalignant disorders, while inter-incisal opening was separately recorded as functional 
staging. 
 
However, significant confusion still exists due to the indiscriminate use of functional, clinical 
and histological components of OSMF in the current classification schemes.2 There is no 
consensus for individual or combined use of these parameters to stage or classify OSMF.2 
Furthermore, existing classification schemes represent only the most prominent lesions 
instead of the potential changes in the rest of the oral cavity. 2-19 Since OSMF has no clear 
and definable borders, it may not be appropriate to use the predominant lesion to indicate the 
complexity of entire OSMF behaviour in the oral mucosa. Therefore, inclusion of the entire 
oral cavity in a holistic approach rather than solely an individual lesion seems reasonable.  
We investigated the agreement between the three main elements of current staging 
(functional, clinical and histological) and histological grading with the aim of possibly using 
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them in combination. We also evaluated the agreement of involvement of oral mucosal 
surfaces with different stages of the diseases.       
 
The results of this study clearly show no agreement between functional and clinical staging (k 
= 0.312) indicating mouth opening is independent of clinical features. Hence there is always a 
greater chance of repetition or difference of clinical symptoms of one stage with functional 
symptoms of another stage (Figure 1A). In some instances, the additional trismus in OSMF 
might be because of impingement of the upper third molar on the coronoid process (Figure 
1B). In such cases, removal of the third molar might significantly improve mouth opening. 
The existing staging schemes seem not to consider trismus due to other factors and may lead 
to false staging.13-19 In severe trismus, it is usually not possible to assess clinical stage due to 
difficulties with visualisation. Therefore, staging only based on functional components may 
not provide all the clinical details. 
 
We found no significant correlation between stages and the number of mucosal surfaces 
affected, suggesting present staging systems do not take into account the number and severity 
of surfaces involved. After analysing the histopathology of 47 random patients with their 
clinical and functional stages, we found no agreement between clinical staging (k =0.167), 
functional staging (k = 0.152), and histological grade (weighted agreement less than 17%).  
 
Since OSMF malignant transformation is known to be independent of stage and site in the 
affected oral cavity (Figure 1C), 23-27 grouping OSMF patients with malignant transformation 
in late stages may result in losing vital data with prognostic value. Hence the validity of any 
clinicopathological classification and its usefulness in treatment planning remains 
questionable. 
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For the first time to our knowledge, we analyzed bilateral buccal mucosa biopsies to further 
evaluate the uniformity of histological grade in multiple oral sites, finding grading agreement 
between bilateral biopsy sites was low (k =-0.478). This finding suggests there may be 
multiple grades of OSMF throughout the oral mucosa.  Existing grading systems signify the 
status of only a prominent lesion chosen by the clinician.14-19   
 
Malignant transformation in OSMF can occur anywhere in the oral cavity.23,25 Unlike oral 
SCC,  OMFS can be diffuse and heterogeneous and be present at different anatomical 
mucosal surfaces and with different behaviours.28,29 It is difficult to conclude that the most 
prominent OSMF lesion represents the status of the entire oral cavity.28 Thus 
histopathological  grading only has a role in understanding the progress of OSMF, but its 
usefulness in monitoring disease progression and overall treatment planning remains 
uncertain.29 Biopsy and histopathological grading are of course important in the diagnosis of 
suspected lesions.26 
 
A systematic classification scheme which utilises all the clinical, functional and histological 
data independently might be helpful and practical for investigating the OSMF complexity.2 A 
comprehensive staging system amassing all the data of the classification would also be 
beneficial to guide treatment plan.  
 
We have developed a three component classification scheme (termed TFM classification) 
which independently assesses all three main OSMF components: trismus, fibrosis, and 
malignant transformation. The use of terms clinical and functional together to categorise 
OSMF seems inappropriate as trismus can also be a clinical feature. Hence trismus and 
fibrosis were used separately to indicate the severity of the disease. In the third component, 
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we combined the suspicious clinical structural changes with histopathological features to aid 
in treatment planning. 
This possible classification has the potential advantage of assessing trismus resulting from 
factors other than mucosal fibrosis, its incidence in edentulous mouth and when clinical 
assessment is not possible due to severe trismus.  
 
The term fibrosis is used to indicate various fibrotic reactions involved in OSMF, such as 
submucosal fibrosis, mucosal scarring and muscular fibrosis. As the histopathological 
evaluation of all the involved oral surfaces is not possible for grading OSMF, we used the 
existing clinical parameters 19 which are indicative of the clinical severity of tissue fibrosis. 
The malignant transformation component assesses the suspicious lesion itself, including 
possible dysplasia and considers when lesions cannot be assessed due to lack of accessibility 
and visibility. Including any dysplasia further allows categorising it as low and high risk 
lesion as recommended by the WHO (2017).30 The TFM classification helps in systematic 
categorizing the information, recording data, proper communication, obtaining prognostic 
information and also to make it easy to understand the disease characteristics which can be 
easily applied by the trainees and clinicians. 
 
Putting together all of our data from the classification, we have developed a three tier staging 
scheme (TFM staging) which allows for differentiation between medical, surgical and 
malignant disease therapy (Table 5). For TFM staging, it is mandatory that the patient should 
at least have stage 1 fibrosis feature (F1) and the patients with no clinical fibrosis (F0) are not 
eligible for TFM staging. In cases where the assessment is not possible (FX, MX), surgical 
evaluation under general anaesthesia is recommended before using any TFM staging is made. 
Though the endoscopic examination of the oral cavity may aid in the evaluation of OSMF in 
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cases of sever trismus, surgical fibrotomy to open the mouth should always be considered 
best practice .24,30  Any suspicious lesions (MQ) or associated potentially malignant disorders 
(MP) should be subjected to histopathology before considering TFM staging.     
 
CONCLUSION: 
 
The complex properties of OSMF including multiple sites with diffuse borders, diverse 
clinical features, and associated trismus pose a clinicopathological challenge for a systematic 
classification and staging system.2,28,29  The present study has found that the different 
components associated with the structural progression of OSMF are independent of each 
other and also the architectural alteration of tissue may not be consistent throughout the oral 
cavity. Thus with current staging classifications there is a potential risk of documenting 
incomplete information, repetition at different stages and incorrect disease interpretation. We 
suggest that the proposed classification scheme describes the disease severity of the 
independent components separately such that the significance of each is meaningfully 
conveyed to the clinician. The staging may also effectively predict the risk of potential 
malignant change. Further work is needed to evaluate and formally validate this proposed 
classification more fully. 
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FIGURE AND TABLE LEGENDS 
Figure 1  
(A) Significant OSMF of pterygomandibular raphe, soft palate and uvula without affecting 
mouth opening   (B) Buccally erupted maxillary third molar impingement causing an 
ulcerative lesion affecting the efficiency of mouth opening in OSMF (C) Malignant changes 
in early stage OSMF 
Table 1 Functional and clinical features of oral submucous fibrosis as proposed by Khanna 
and Andrade19  
Table 2 Histological features of oral submucous fibrosis as proposed by Khanna and 
Andrade19 
Table 3 Cross-tabulation of bilateral biopsy grading 
Table 4 Parameters of TFM classification 
Table 5 Proposed TFM staging of oral submucous fibrosis 
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Table 1: Functional and clinical features of oral submucous fibrosis as proposed by Khanna and 
Andrade19  
  
Stage Functional staging Clinical staging
 
 
Stage 1 
 
Interincisal 
openings  
of 35 mm and 
above 
• Burning sensation in the mouth, 
• Acute ulceration and recurrent 
stomatitis 
• No associated mouth opening limitation 
 
 
 
Stage 2 
 
 
Interincisal 
openings  
of 26-35 mm 
• Mottled and marble-like buccal mucosa 
• Dense, pale, depigmented fibrosed 
areas alternated with pink normal mucosa 
• Occasional red erythroplakic patches 
• Widespread sheets of fibrosis 
 
 
 
 
 
 
Stage 3 
 
 
 
 
 
Interincisal 
opening  
of 15-25 mm 
• Pale buccal mucosa firmly attached to 
the underlying tissues 
• Palpable vertical fibrous bands in the 
premolar area 
• Unable to blow out cheeks and whistle 
• In the soft palate, the fibrous bands 
were seen to radiate from the 
pterygomandibular raphe or the anterior faucial 
pillar in a scar-like appearance 
• The lips may be affected with atrophy 
of the vermilion border 
 
 
 
 
Stage 4 
(4a and 
4b) 
 
 
 
Interincisal 
opening  
of 15 mm and 
below 
• Thickened, shortened, and firm fauces, 
with the tonsils compressed between the 
fibrosed pillars 
• Small, 
shrunken, fibrous bud uvula 
• Narrowed isthmus, presence of circular 
band around entire lip and mouth 
• Restricted 
tongue movement, diffuse papillary atrophy 
• Atrophy of the vermilion border. 
• Premalignant and malignant changes 
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Table 2: Histological features of oral submucous fibrosis as proposed by Khanna and Andrade19  
 
  
Grade  Histopathology grading 
 
 
 
I 
• Fine fibrillar collagen network interspersed with marked edema 
• Dilated  and   congested blood vessels 
• Large aggregate of plump, young fibroblasts containing abundant cytoplasm 
• Inflammatory cells mainly consisting of polymorphonuclear leukocytes with few 
eosinophils 
• Normal,  nonkeratinized epithelium with occasionally some hyperplasia 
 
 
 
             II 
• Juxta-epithelial hyalinization 
• Separate bundles of  thickened collagen 
• Dilated and congested blood vessels 
• Moderate number of young fibroblasts 
• Inflammatory cells mainly consisting of polymorphonuclear leukocytes with few 
eosinophils and occasional plasma cells 
• Flattening or shortening of epithelial rete-pegs with varying degree of  
keratinization 
 
 
 
 
             III 
• Juxta-epithelial hyalinization 
• Faintly discernible thickened collagen bundles separated by very slight, residual 
edema 
• Constricted blood vessels 
• Mature fibroblasts with scanty cytoplasm and spindle-shaped nuclei 
• Inflammatory exudates consisting of lymphocytes and plasma cells 
• Markedly atrophic epithelium with loss of rete pegs 
• Muscle fibers seen with thickened and dense collagen fibers 
• Early signs of muscular degeneration with irregularity of the striae 
              
 
 
           IV 
(IV a and  IV b) 
• Smooth sheet of hyalinized collagen  without any evidence of individual bundles  
• Extensive fibrosis with obliterated the mucosal blood vessels 
• Incontinentia pigmenti 
• Absence of fibroblasts within the hyalinized zones 
• Total loss of epithelial rete pegs 
• Mild to moderate epithelial dysplasia 
• Extensive degeneration of muscle fibers 
• Evidence of  malignant transformation  
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Table 3 Cross-tabulation of bilateral biopsy grading 
Biopsy grading 
right buccal 
mucosa  
Histopathological  grading left buccal mucosa
Grade 1 Grade 2 Grade 3 Grade 4 
Grade 1 
Grade 2 
Grade 3 
Grade 4 
0 
8 
6 
0 
6 
0 
3 
0 
2 
0 
0 
0 
0 
0 
0 
0 
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Table 4 Parameters of TFM classification 
 
 
  
Trismus (T)  
TX Trismus cannot be assessed due to presence of confounding factors such as tooth 
impingement, Temporomandibular join disorders (TMDs), infection etc 
T0 Interincisal distance of more than 36mm 
T1 Interincisal distance of 26 to 35 mm 
T2 Interincisal distance of 15 to 25 mm
T3 Interincisal distance of less than 15 mm
  TE Edentulous (E) state due to either complete or partial loss of anterior teeth 
TE0 Anterior free space after maximum mouth opening more than 41 mm 
TE1 Anterior free space after maximum mouth opening of 36 to 40 mm 
TE2 Anterior free space after maximum mouth opening of 25to 35 mm 
TE3 Anterior free space after maximum mouth opening of less than 25 mm 
Fibrosis (F) 
F0 No signs of fibrosis 
FX Fibrosis cannot be assessed due to severe trismus
F1 
 
Burning sensation in the mouth and/or blanching of oral mucosa and/or acute 
ulceration and/or recurrent stomatitis  
F2 
 
Mottled and marble like oral mucosa, dense, pale, depigmented fibrosed areas 
alternated with pink normal mucosa,  widespread sheets of fibrosis (palpable 
fibrous bands)  involving  labial and/or buccal mucosa and/or oropharynx 
 
F3 
 
Pale oral mucosa firmly attached to underlying tissues,  palpable vertical fibrous 
bands at the buccal mucosa,  in the soft palate-radiating fibrous bands from the 
pterygomandibular raphe or the anterior faucial pillar in a scar-like appearance,  
atrophy of the vermilion border, patient unable to blow out cheeks and whistle 
F4 
 
Thickened faucial pillars, shrunken -fibrous bud like small uvula,  narrowed 
isthmus, restricted tongue movement, diffuse papillary atrophy, palpable circular 
fibrous band around entire mouth, obliquity of rima oris, vermilion border 
atrophy  
Malignant Transformation (M ) 
M0 No signs of malignant transformation 
MX Malignant transformation cannot be assessed  due to severe trismus 
MQ Lesion in question 
MP Associated potentially malignant disorder
M1 Histopathological evidence of dysplasia
M1a Low -grade  
M1b High- grade  
M2 Histopathological evidence of malignant transformation
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Table 5  TFM staging of oral submu
 
 
 
 
Stage 
Stage 1 (Medical Therapy) 
Stage 2 (Surgical Therapy) 
Stage 3 ( Neoplastic disease therapy )
cous fibrosis  
 
 
 
 
 
TFM classification 
T0-2/ E0-E2 or F1-2, M0,1a 
T2-3/E2-E3 or F3-4, M0,1b 
 Any T
 , F1-4, M2 
 
